Life Science REIT Alexandria Marks 30th Anniversary
Alexandria Real Estate Equities, Inc., a pioneer developer of collaborative life science, agtech and advanced technology mega-campuses, marked the 30th anniversary of its founding on Friday. Launched on Jan. 5, 1994, the Pasadena-based company is reportedly the only publicly traded pure-play life science REIT.
“Thirty years ago, we saw the remarkable early potential of the life science industry, and today we are honored to be the trusted partner to leaders in this secularly growing industry who rely on our essential Labspace assets to advance and help safeguard their mission-critical work on truly groundbreaking therapies and cures,” said Joel S. Marcus, executive chairman and founder of Alexandria Real Estate Equities, Inc./Alexandria Venture Investments. The company said half of all FDA-approved therapies since 2013 have come through Alexandria tenants.
From its IPO in May 1997 through December 31, 2023, Alexandria has generated a TSR of 1,512%, outperforming major indices over the same period, including the FTSE Nareit Equity Health Care Index’s TSR of 980% and the MSCI US REIT Index’s TSR of 792%.
Pictured: Alexandria’s New York City campus.